Table 1.
Baseline characteristics between statin and comparison groups
| Factor | Statin Group (N = 10,104) |
Comparison Group (N = 10,104) |
P-value |
|---|---|---|---|
| Socio-Demographic (%, n) | |||
| Age (Mean ± SD, n), year | 64.80 ± 10.32 (10,104) | 64.82 ± 11.19 (10,104) | 0.889 |
| Gender | 0.743 | ||
| Female | 58.19% (5880) | 58.42% (5903) | |
| Male | 41.81% (4224) | 41.58% (4201) | |
| Smoking Status | 0.796 | ||
| Non-smoker | 89.96% (9090) | 90.07% (9101) | |
| Smoker | 10.04% (1014) | 9.93% (1003) | |
| Clinical Parameters (Mean ± SD) | |||
| HbA1c, % | 7.31 ± 1.28 (10,104) | 7.30 ± 1.33 (10,104) | 0.505 |
| SBP, mmHg | 134.98 ± 16.51 (10,104) | 134.85 ± 16.88 (10,104) | 0.580 |
| DBP, mmHg | 74.94 ± 9.92 (10,104) | 74.91 ± 10.05 (10,104) | 0.865 |
| LDL-C, mmol/L | 3.76 ± 0.63 (10,104) | 3.75 ± 0.64 (10,104) | 0.615 |
| BMI, kg/m2 | 25.73 ± 3.88 (10,104) | 25.79 ± 3.91 (10,104) | 0.289 |
| TC/ HDL-C Ratio | 4.76 ± 1.11 (10,104) | 4.76 ± 1.09 (10,104) | 0.997 |
| Triglyceride, mmol/L | 1.61 ± 0.79 (10,104) | 1.62 ± 0.86 (10,104) | 0.600 |
| Disease Characteristics (%, n) | |||
| Duration of DM (Mean ± SD), years | 7.11 ± 6.38 (10,104) | 7.10 ± 6.25 (10,104) | 0.881 |
| Presence of Chronic Kidney Disease (%, n) | 4.13% (417) | 3.96% (400) | 0.544 |
| Charlson’s Index (Mean ± SD) | 3.95 ± 1.05 (10,104) | 3.96 ± 1.12 (10,104) | 0.496 |
| Hypertension | 75.81% (7660) | 75.93% (7672) | 0.844 |
| Family History of DM | 46.61% (4709) | 47.01% (4750) | 0.563 |
| Treatment Modalities (%, n) | |||
| Use of Insulin | 1.39% (140) | 1.44% (145) | 0.765 |
| Use of Oral Diabetic Drugs | 88.08% (8900) | 87.91% (8882) | 0.697 |
| Use of Anti-Hypertensive Drugs | 78.66% (7948) | 79.05% (7987) | 0.502 |
HbA1c Haemoglobin A1c, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, LDL-C Low Density Lipoprotein - Cholesterol, BMI Body Mass Index, TC Total Cholesterol, HDL-C High Density Lipoprotein - Cholesterol, DM Diabetes Mellitus
*Significant with p-value <0.05 by chi-square test or t-test as appropriate